Image Place holder

Susan J. Hoover, MD, FACS

Specialty: Surgery
Program: Breast Oncology

Call 1-888-MOFFITT

Call 1-888-MOFFITT

Locations: Moffitt Cancer Center at International Plaza
Moffitt McKinley Outpatient Center

Cancer Types Treated: Invasive Ductal Carcinoma , Triple Negative Breast Cancer , Breast Cancer, Ductal Carcinoma In Situ , Inflammatory Breast Cancer

Dr. Susan Hoover is a board certified surgical oncologist specializing in breast cancer in the Moffitt Cancer Center Department of Breast Oncology. She returned to Moffitt after several years of practice at the MD Anderson Cancer Center in Houston, Texas. In addition to performing breast surgeries, such as mastectomies and lumpectomies, she has special expertise in minimally-invasive surgery techniques, incorporating sentinel lymph node biopsy, breast ultrasound, breast needle biopsy and accelerated partial breast irradiation into her patient care. Dr. Hoover has held national committee appointments in the Society for Surgical Oncology, the American Society of Breast Surgeons and the Association of Women Surgeons. She has been chosen by her peers for listing in Best Doctors in America® since 2009.  

Education & Training

Board Certification:

  • Surgical Oncology


  • University of Texas Southwestern, Dallas, TX - Breast Fellowship


  • University of Texas Southwestern, Dallas, TX - General Surgery

Medical School:

  • University of Texas Southwestern, Dallas, TX - MD
Participating Trials

A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Condition: Breast
Intervention: Not Applicable

An Open-Label, Single-Arm, Phase 2 Study Of Avb-620 In Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Condition: Breast
Intervention: AVB-620

A Phase II Study of Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer: Introduction of a Novel Form of Accelerated Partial Breast Radiotherapy
Condition: Breast
Intervention: Not Applicable

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.


  • Mills MN, Yang GQ, Oliver DE, Liveringhouse CL, Ahmed KA, Orman AG, Laronga C, Hoover SJ, Khakpour N, Costa RLB, Diaz R. Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysis. Eur J Cancer. 2018 Jul;98:48-58. Pubmedid: 29870876.
  • Mattingly AE, Ma Z, Smith PD, Kiluk JV, Khakpour N, Hoover SJ, Laronga C, Lee MC. Early Postoperative Complications after Oncoplastic Reduction. South Med J. 2017 Oct;110(10):660-666. Pubmedid: 28973708.
  • Mattingly AE, Mooney B, Lin HY, Kiluk JV, Khakpour N, Hoover SJ, Laronga C, Lee MC. Magnetic Resonance Imaging for Axillary Breast Cancer Metastasis in the Neoadjuvant Setting: A Prospective Study. Clin Breast Cancer. 2017 Jun;17(3):180-187. Pubmedid: 27956116.
  • Mellon EA, Orman A, Joya LE, Montejo ME, Laronga C, Hoover SJ, Lee MC, Khakpour N, Kubal PF, Diaz R. Frequency of whole breast radiation therapy after intraoperative radiation therapy due to criteria identified by lumpectomy. Brachytherapy. 2017 Jul;16(1):174-180. Pubmedid: 27816540.
  • Khazai L, Chau A, Hoover S, Rosa M. Papillary endothelial hyperplasia arising in the irradiated breast: A diagnostic dilemma. Pathol Res Pract. 2016 Jul;212(7):604-607. Pubmedid: 27157404.
  • Zimmerman A, Locke FL, Emole J, Rosa M, Horna P, Hoover S, Dayicioglu D. Recurrent Systemic Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma Presenting as a Breast Implant-Associated Lesion. Cancer Control. 2015 Jul;22(3):369-373. Pubmedid: 26351895.
  • Jafarian N, Kuppler K, Rosa M, Hoover S, Patel B. Chronic Lymphocytic Leukemia and Invasive Ductal Carcinoma Presenting as a Collision Breast Tumor. Clin Breast Cancer. 2015 Aug;15(4):e209-e212. Pubmedid: 25818398.
  • Hoover S, Bloom E, Patel S. Review of breast conservation therapy: then and now. ISRN Oncol. 2012 Aug;2011:617593. Pubmedid: 22229101. Pmcid: PMC3200284.
  • Sarnaik AA, Meade T, King J, Acs G, Hoover S, Cox CE, Carter WB, Laronga C. Adenoid cystic carcinoma of the breast: a review of a single institution's experience. Breast J. 2010 May;16(2):208-210. Pubmedid: 20030648.
  • Laronga C, Lee MC, McGuire KP, Meade T, Carter WB, Hoover S, Cox CE. Indications for sentinel lymph node biopsy in the setting of prophylactic mastectomy. J Am Coll Surg. 2009 Dec;209(6):746-752. Pubmedid: 19959044.
  • Hoover SJ, Berry MP, Rossick L, Rege RV, Jones DB. Ultrasound-guided breast biopsy curriculum for surgical residents. Surg Innov. 2008 Mar;15(1):52-58. Pubmedid: 18407929.
  • Kiluk J, Acs G, Hoover S. High-risk benign breast lesions: current strategies in management. Cancer Control. 2007 Oct;14(4):321-329. Pubmedid: 17914332.
  • Laronga C, Hasson D, Hoover S, Cox J, Cantor A, Cox C, Carter W. Paget's disease in the era of sentinel lymph node biopsy. Am J Surg. 2006 Oct;192(4):481-483. Pubmedid: 16978954.
  • Bevers TB, Anderson BO, Bonaccio E, Borgen PI, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE, Helvie M, Hoover S, Krontiras H, Shaw S, Singletary E, Sugg Skinner C, Smith ML, Tsangaris TN, Wiley EL, Williams C. Breast cancer screening and diagnosis. J Natl Compr Canc Ne. 2006 May;4(5):480-508. Pubmedid: 16687096.
  • Johnson-Maddux A, Ashfaq R, Cler L, Naftalis E, Leitch AM, Hoover S, Euhus DM. Reproducibility of cytologic atypia in repeat nipple duct lavage. Cancer. 2005 Mar;103(6):1129-1136. Pubmedid: 15685620.
  • Maddux AJ, Ashfaq R, Naftalis E, Leitch AM, Hoover S, Euhus D. Patient and duct selection for nipple duct lavage. Am J Surg. 2004 Oct;188(4):390-394. Pubmedid: 15474432.
  • Meng S, Tripathy D, Shete S, Ashfaq R, Haley B, Perkins S, Beitsch P, Khan A, Euhus D, Osborne C, Frenkel E, Hoover S, Leitch M, Clifford E, Vitetta E, Morrison L, Herlyn D, Terstappen LW, Fleming T, Fehm T, Tucker T, Lane N, Wang J, Uhr J. HER-2 gene amplification can be acquired as breast cancer progresses. Proc Natl Acad Sci U S A. 2004 Jun;101(25):9393-9398. Pubmedid: 15194824. Pmcid: PMC438987.
  • Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, Beitsch PD, Leitch M, Hoover S, Euhus D, Haley B, Morrison L, Fleming TP, Herlyn D, Terstappen LW, Fehm T, Tucker TF, Lane N, Wang J, Uhr JW. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res. 2004 Dec;10(24):8152-8162. Pubmedid: 15623589.